The Rheumatologist

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session. The post As Understanding of […]

At this ACR Convergence 2025 session, two experts discussed VEXAS & the role that genetic sequencing should play in the

At this ACR Convergence 2025 session, experts discussed the oral manifestations of scleroderma & Sjögren’s disease & the importance of

The gut microbiome may trigger RA & predict methotrexate response. ACR Convergence 2025 experts discuss pathogenesis & drug efficacy. The

As the uses for artificial intelligence grow within rheumatology, so do the benefits and the concerns about the technology. In

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis

In this review, some of the many abstracts on research into lupus nephritis presented at ACR Convergence 2025 are highlighted.

Urinary biomarkers may have the potential to detect early treatment responses or failures in patients with lupus nephritis, according to

Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s

At this ACR Convergence 2025 session, experts discussed the importance of vaccinating immunocompromised patients with non-live vaccines. The post Using

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically

Experts discuss HIIT as an underused ‘disease-modifying drug’ for inflammatory diseases. Learn how to safely integrate it into patient treatment

CPPD diagnosis is difficult & treatments are limited. Experts review radiology challenges, off-label options like colchicine, & emerging biologics. The

Richard F. Loeser, Jr., MD, MACR, delivering the Oscar Gluck Memorial Lecture at ACR Convergence 2025, discussed research into new

Why do lymphatics fail in inflammatory arthritis? Research from ACR 2025 points to a network of telocytes & mast cells

At ACR Convergence 2025, Joan T. Merrill, MD, overviewed the current research landscape of chimeric antigen receptor (CAR) T cell

At this ACR Convergence 2025 session, immunologist Dusan Bogunovic, PhD, discussed his team’s research into how genetic immune diseases manifest

At this ACR Convergence 2025 session, experts discussed emerging concepts with axial spondyloarthritis, including the most effective MRI specifications for

Immune mediated inflammatory myopathies represent a heterogenous group of diseases with variable degrees of multisystem involvement, including the skin, joints,

Experts share tips for building & managing a profitable rheumatology infusion practice, from staffing & billing to inventory & drug

At the Dubois Memorial Lecture presented at ACR Convergence 2025, Shaun Jackson, MD, PhD, discussed the evolving understanding of the

The post ACR Convergence 2025: Video Highlights appeared first on The Rheumatologist.

This year’s Opening Session of ACR Convergence 2025 featured a well-known thought leader on physician burnout, Dr. Tait Shanafelt, who

In a panel discussion at ACR Convergence 2025, three experts provided insight into how mentorship, personal values and more helped

ACR Convergence 2025 speakers reviewed new fibromyalgia insights, from the first new drug approval since 2009 to nociplastic pain concepts

At a scientific session of ACR Convergence 2025, Alexis Ogdie, MD, discussed new and forthcoming treatments for psoriatic arthritis. The

Incoming ARP President Dr. Rebecca Cleveland discusses her plans for advocacy, ACR/ARP collaboration, & tackling workforce shortages in rheumatology. The